Search

Your search keyword '"Laghi Pasini, F"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Laghi Pasini, F" Remove constraint Author: "Laghi Pasini, F" Search Limiters Full Text Remove constraint Search Limiters: Full Text
109 results on '"Laghi Pasini, F"'

Search Results

1. Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date

6. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia

7. Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study

8. Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study

9. Risk factors for hospital readmission of elderly patients

10. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly

12. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults.

13. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults

15. Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series.

16. Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature.

17. Development and preliminary validation of a diagnostic score for identifying patients affected with adult-onset autoinflammatory disorders.

20. Increase in plasma levels of adenosine and adenine nucleotides after intravenous infusion of buflomedil in humans

24. Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly

28. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome

30. Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults

31. Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.

32. Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies.

33. Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans.

34. Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults.

36. Interleukin-6 Elevation Is a Key Pathogenic Factor Underlying COVID-19-Associated Heart Rate-Corrected QT Interval Prolongation.

37. Transient Hypogonadism Is Associated With Heart Rate-Corrected QT Prolongation and Torsades de Pointes Risk During Active Systemic Inflammation in Men.

38. Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine-Mediated Inhibition of Connexin43 Expression.

39. Anti-Ro/SSA Antibodies and the Autoimmune Long-QT Syndrome.

40. Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine.

41. Proton Pump Inhibitors Directly Block hERG-Potassium Channel and Independently Increase the Risk of QTc Prolongation in a Large Cohort of US Veterans.

42. Risk of QTc Interval Prolongation Associated With Circulating Anti-Ro/SSA Antibodies Among US Veterans: An Observational Cohort Study.

43. IL-6 (Interleukin 6) Blockade and Heart Rate Corrected QT Interval Prolongation in COVID-19.

44. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-Mediated Effects on Potassium Channel Expression.

45. Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes.

47. Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression.

48. Autoimmune Calcium Channelopathies and Cardiac Electrical Abnormalities.

49. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation.

Catalog

Books, media, physical & digital resources